Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke: A Nationwide, Multicenter Registry-Based Study.

MLA

Kim, Joon-Tae, et al. “Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke: A Nationwide, Multicenter Registry-Based Study.” Stroke (00392499), vol. 50, no. 11, Nov. 2019, pp. 3147–55. EBSCOhost, https://doi.org/10.1161/STROKEAHA.119.026044.

APA

Kim, J.-T., Park, M.-S., Choi, K.-H., Cho, K.-H., Kim, B. J., Park, J.-M., Kang, K., Lee, S. J., Kim, J. G., Cha, J.-K., Kim, D.-H., Park, T. H., Park, S.-S., Lee, K. B., Lee, J., Hong, K.-S., Cho, Y.-J., Park, H.-K., Lee, B.-C., & Yu, K.-H. (2019). Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke: A Nationwide, Multicenter Registry-Based Study. Stroke (00392499), 50(11), 3147–3155. https://doi.org/10.1161/STROKEAHA.119.026044

Chicago

Kim, Joon-Tae, Man-Seok Park, Kang-Ho Choi, Ki-Hyun Cho, Beom Joon Kim, Jong-Moo Park, Kyusik Kang, et al. 2019. “Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke: A Nationwide, Multicenter Registry-Based Study.” Stroke (00392499) 50 (11): 3147–55. doi:10.1161/STROKEAHA.119.026044.